Activation of TRPV1 and TRPA1 on meningeal nerve endings induces the release of vasoactive neuropeptides CGRP and substance P and contributes to different forms of headache including migraine (Giniatullin et al., 2008; Benemei et al., 2013). This evidence concerns the gene TRPV1 and migraine disorder.